Stock Events

Stock Events

Vanda Pharmaceuticals (VNDA) Q1 2026 Earnings

11FebConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-2.39

-1.71

-1.03

-0.36

Details

Expected EPS

-0.975

Actual EPS

-2.39

Surprise EPS

-1.42

Surprise Percent

+145.13%

Description

Vanda Pharmaceuticals (VNDA) has reported earnings of -2.39 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.